U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C25H48N6O10
Molecular Weight 592.6828
Optical Activity UNSPECIFIED
Defined Stereocenters 12 / 12
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PLAZOMICIN

SMILES

CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@@H](C[C@H](N)[C@@H](O[C@H]3OC(CNCCO)=CC[C@H]3N)[C@@H]2O)NC(=O)[C@@H](O)CCN)OC[C@]1(C)O

InChI

InChIKey=IYDYFVUFSPQPPV-PEXOCOHZSA-N
InChI=1S/C25H48N6O10/c1-25(37)11-38-24(18(35)21(25)29-2)41-20-15(31-22(36)16(33)5-6-26)9-14(28)19(17(20)34)40-23-13(27)4-3-12(39-23)10-30-7-8-32/h3,13-21,23-24,29-30,32-35,37H,4-11,26-28H2,1-2H3,(H,31,36)/t13-,14+,15-,16+,17+,18-,19-,20+,21-,23-,24-,25+/m1/s1

HIDE SMILES / InChI

Molecular Formula C25H48N6O10
Molecular Weight 592.6828
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 12 / 12
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 01:40:40 UTC 2023
Edited
by admin
on Sat Dec 16 01:40:40 UTC 2023
Record UNII
LYO9XZ250J
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PLAZOMICIN
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
(2S)-4-AMINO-N-((1R,2S,3S,4R,5S)-5-AMINO-4-(((2S,3R)-3-AMINO-6-(((2-HYDROXYETHYL)AMINO)METHYL)-3,4-DIHYDRO-2H-PYRAN-2-YL)OXY)-2-((3-DEOXY-4-C-METHYL-3-(METHYLAMINO)-.BETA.-L-ARABINOPYRANOSYL)OXY)-3-HYDROXYCYCLOHEXYL)-2-HYDROXYBUTANAMIDE
Common Name English
Plazomicin [WHO-DD]
Common Name English
PLAZOMICIN [MI]
Common Name English
plazomicin [INN]
Common Name English
ACHN-490
Code English
PLAZOMICIN [USAN]
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID001031303
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
FDA UNII
LYO9XZ250J
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
DRUG CENTRAL
5287
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
INN
9522
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
SMS_ID
100000175065
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
WIKIPEDIA
Plazomicin
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
RXCUI
2049549
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
DAILYMED
LYO9XZ250J
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
USAN
YY-39
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
CAS
1154757-24-0
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
MERCK INDEX
m12109
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
NCI_THESAURUS
C174680
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
ChEMBL
CHEMBL1650559
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
LACTMED
Plazomicin
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
PUBCHEM
42613186
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
DRUG BANK
DB12615
Created by admin on Sat Dec 16 01:40:40 UTC 2023 , Edited by admin on Sat Dec 16 01:40:40 UTC 2023
PRIMARY
Related Record Type Details
TRANSPORTER -> INHIBITOR
TARGET ORGANISM->INHIBITOR
EXCRETED UNCHANGED
Following a single IV dose of 15 mg/kg radiolabeled plazomicin, approximately 97.5% of the dose was recovered in the urine as unchanged plazomicin.
URINE
TRANSPORTER -> INHIBITOR
TARGET ORGANISM->INHIBITOR
BINDER->LIGAND
BINDING
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC